Douglas B. Snyder

CIK: 0001754125

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IDYA

IDEAYA Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

IDYA
IDEAYA Biosciences, Inc.
Jan 30, 2026
Award(A)
Stock Option (right to buy)
Direct
130K shares-
IDYA
IDEAYA Biosciences, Inc.
Nov 28, 2025
Award(A)
Direct
1K shares at avg. $16.91$18K
IDYA
IDEAYA Biosciences, Inc.
May 30, 2025
Award(A)
Direct
1K shares at avg. $16.91$18K
IDYA
IDEAYA Biosciences, Inc.
Feb 27, 2025
Award(A)
Stock Option (right to buy)
Direct
33K shares-
IDYA
IDEAYA Biosciences, Inc.
Sep 26, 2024
Award(A)
Stock Option (Right to Buy)
Direct
140K shares-

		Type	Shares	Price		Ownership
Jan 30, 2026	IDYA IDEAYA Biosciences, Inc.	Award(A) Stock Option (right to buy)	130,000	-	-	Direct
Nov 28, 2025	IDYA IDEAYA Biosciences, Inc.	Award(A)	1,041	$16.91	$17,600	Direct
May 30, 2025	IDYA IDEAYA Biosciences, Inc.	Award(A)	1,039	$16.91	$17,566	Direct
Feb 27, 2025	IDYA IDEAYA Biosciences, Inc.	Award(A) Stock Option (right to buy)	33,000	-	-	Direct
Sep 26, 2024	IDYA IDEAYA Biosciences, Inc.	Award(A) Stock Option (Right to Buy)	140,000	-	-	Direct

1-5 of 5 transactions

About Snyder Douglas B.

Snyder Douglas B. (SEC CIK 0001754125) files insider reports with the SEC as SVP, General Counsel of IDEAYA Biosciences, Inc. (IDYA).

Signal8 holds 4 ownership filings by Snyder Douglas B. (1 Form 3, 3 Form 4), filed between Sep 27, 2024 and Feb 2, 2026. Those filings report 5 transactions, from Sep 26, 2024 to Jan 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Snyder Douglas B.'s filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Snyder Douglas B.

Jan 30, 2026: Grant or award of IDYA derivative securities (Form 4, code A).
Nov 28, 2025: Grant or award of IDYA shares (Form 4, code A).
May 30, 2025: Grant or award of IDYA shares (Form 4, code A).
Feb 27, 2025: Grant or award of IDYA derivative securities (Form 4, code A).
Sep 26, 2024: Grant or award of IDYA derivative securities (Form 4, code A).

Other insiders filing for IDEAYA Biosciences, Inc. (IDYA)

Hata Yujiro S, President and CEO
Ruiz Briseno Andres, Chief Accounting Officer
YARNO WENDY L, Director
Stein Jeffrey, Director
ROSEN TERRY J, Director
Morrison Scott W, Director

How to read Form 4 transaction codes